Further potential savings attributable to maximum generic substitution of antidepressants in South Africa: A retrospective analysis of medical claims
The main objective of the study was to calculate potential cost savings that could have been generated by maximum generic substitution of antidepressants within the private health care sector of South Africa from 2004 to 2006. Data on computerised medicine claims of patients receiving one or more an...
Saved in:
Main Authors: | Elmarie van der Westhuizen (Author), Johanita R. Burger (Author), Martie S. Lubbe (Author), Jan H.P. Serfontein (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2010-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Maximum potential cost-savings attributable to generic substitution of antipsychotics 2008 to 2013
by: D. Husselmann, et al.
Published: (2016) -
Maximum potential cost-savings attributable to generic substitution of antipsychotics 2008 to 2013
by: D. Husselmann, et al.
Published: (2016) -
Prescribing patterns of medicine classified as 'antidepressants' in South African children and adolescents
by: Johanita R. Burger, et al.
Published: (2009) -
Investigation into the prescribing patterns and cost of antidiabetic medicine in South Africa
by: Rianda Steyn, et al.
Published: (2007) -
Childhood cancers in a section of the South African private health sector: Analysis of medicines claims data
by: Marianne N. Otoo, et al.
Published: (2020)